Your browser doesn't support javascript.
loading
Spatiotemporally Skewed Activation of Programmed Cell Death Receptor 1-Positive T Cells after Epstein-Barr Virus Infection and Tumor Development in Long-Term Fully Humanized Mice.
Danisch, Simon; Slabik, Constanze; Cornelius, Angela; Albanese, Manuel; Tagawa, Takanobu; Chen, Yen-Fu A; Krönke, Nicole; Eiz-Vesper, Britta; Lienenklaus, Stefan; Bleich, Andre; Theobald, Sebastian J; Schneider, Andreas; Ganser, Arnold; von Kaisenberg, Constantin; Zeidler, Reinhard; Hammerschmidt, Wolfgang; Feuerhake, Friedrich; Stripecke, Renata.
Afiliação
  • Danisch S; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany; Laboratory of Regenerative Immune Therapies Applied, Excellence Cluster REBIRTH and German Centre for Infection Research, Partner Site Hannover, Hannover, Germany.
  • Slabik C; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany; Laboratory of Regenerative Immune Therapies Applied, Excellence Cluster REBIRTH and German Centre for Infection Research, Partner Site Hannover, Hannover, Germany.
  • Cornelius A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany; Laboratory of Regenerative Immune Therapies Applied, Excellence Cluster REBIRTH and German Centre for Infection Research, Partner Site Hannover, Hannover, Germany.
  • Albanese M; Research Unit Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health and German Centre for Infection Research, Partner Site Munich, Munich, Germany.
  • Tagawa T; Research Unit Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health and German Centre for Infection Research, Partner Site Munich, Munich, Germany.
  • Chen YA; Research Unit Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health and German Centre for Infection Research, Partner Site Munich, Munich, Germany.
  • Krönke N; Institute of Pathology, Hannover Medical School, Hannover, Germany.
  • Eiz-Vesper B; Institutes for Transfusion Medicine, Hannover Medical School, Hannover, Germany.
  • Lienenklaus S; Laboratory Animal Science, Hannover Medical School, Hannover, Germany.
  • Bleich A; Laboratory Animal Science, Hannover Medical School, Hannover, Germany.
  • Theobald SJ; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany; Laboratory of Regenerative Immune Therapies Applied, Excellence Cluster REBIRTH and German Centre for Infection Research, Partner Site Hannover, Hannover, Germany.
  • Schneider A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany; Laboratory of Regenerative Immune Therapies Applied, Excellence Cluster REBIRTH and German Centre for Infection Research, Partner Site Hannover, Hannover, Germany.
  • Ganser A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • von Kaisenberg C; Department of Obstetrics, Gynecology and Reproductive Medicine, Hannover Medical School, Hannover, Germany.
  • Zeidler R; Research Unit Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health and German Centre for Infection Research, Partner Site Munich, Munich, Germany; Department of Otorhinolaryngology, Klinikum der Universität and German Centre for Infection Research, Partner Site Mu
  • Hammerschmidt W; Research Unit Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health and German Centre for Infection Research, Partner Site Munich, Munich, Germany.
  • Feuerhake F; Institute of Pathology, Hannover Medical School, Hannover, Germany; Institute for Neuropathology, University Clinic Freiburg, Freiburg, Germany.
  • Stripecke R; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany; Laboratory of Regenerative Immune Therapies Applied, Excellence Cluster REBIRTH and German Centre for Infection Research, Partner Site Hannover, Hannover, Germany. Electronic add
Am J Pathol ; 189(3): 521-539, 2019 03.
Article em En | MEDLINE | ID: mdl-30593822
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Herpesvirus Humano 4 / Linfócitos T CD8-Positivos / Infecções por Vírus Epstein-Barr / Receptor de Morte Celular Programada 1 / Proteínas de Neoplasias / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Herpesvirus Humano 4 / Linfócitos T CD8-Positivos / Infecções por Vírus Epstein-Barr / Receptor de Morte Celular Programada 1 / Proteínas de Neoplasias / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article